Sarah Beck
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 16
- Platelet Disorders and Treatments 16
- Blood groups and transfusion 2
-
- Blood properties and coagulation 7
- Co-authors
- Teresa Klinowska (3 shared papers)Bernhard Nieswandt (20 shared papers)Elaine Kilgour (2 shared papers)Tanya Coleman (2 shared papers)Lorraine Mooney (2 shared papers)Martine J. Mellor (2 shared papers)Paul R. Gavine (2 shared papers)Dawn Baker (2 shared papers)
- Journals
- Blood Advances (5 papers)Blood (4 papers)Journal of Thrombosis and Haemostasis (3 papers)Haematologica (2 papers)Cancer Research (2 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Sarah Beck
29 papers receiving 1.0k citations
Sarah Beck's Hit Papers
Peers
Comparison fields: 5 of 79
- Hematology 258
- Internal Medicine 63
- Immunology and Allergy 51
- Molecular Biology 499
- Oncology 175
Countries citing papers authored by Sarah Beck
This map shows the geographic impact of Sarah Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Beck more than expected).
Fields of papers citing papers by Sarah Beck
This network shows the impact of papers produced by Sarah Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Beck. The network helps show where Sarah Beck may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family Hit paper breakdown → | 2012 | 416 |
| 2 | 2010 | 96 | |
| 3 | 2016 | 62 | |
| 4 | 2016 | 56 | |
| 5 | 2017 | 55 | |
| 6 | 2017 | 40 | |
| 7 | 2019 | 34 | |
| 8 | 2006 | 30 | |
| 9 | 2022 | 30 | |
| 10 | 2020 | 26 | |
| 11 | 2017 | 24 | |
| 12 | 2015 | 20 | |
| 13 | 2020 | 18 | |
| 14 | 2021 | 17 | |
| 15 | 2022 | 17 | |
| 16 | 2024 | 17 | |
| 17 | 2023 | 14 | |
| 18 | 2022 | 14 | |
| 19 | 2011 | 11 | |
| 20 | 2018 | 9 |
About Sarah Beck
Sarah Beck is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Oncology, Immunology and Allergy and Molecular Biology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (16 papers), Blood properties and coagulation (7 papers), Cell Adhesion Molecules Research (6 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Blood groups and transfusion (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), HER2/EGFR in Cancer Research (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hematology (258 citations), Internal Medicine (63 citations), Immunology and Allergy (51 citations), Molecular Biology (499 citations) and Oncology (175 citations). Sarah Beck has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Teresa Klinowska, Bernhard Nieswandt, Elaine Kilgour, Tanya Coleman, Lorraine Mooney, Martine J. Mellor, Paul R. Gavine, Dawn Baker, Katherine Al-Kadhimi and Andrew P. Thomas. Their work appears in journals such as Blood Advances, Blood, Journal of Thrombosis and Haemostasis, Haematologica and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.